Principal Investigator, Greater Southern California Node, NIDA CTN
Professor, Dept. Of Psychiatry And Biobehavioral Sciences
Director, Addiction Psychiatry Division
Geffen School Of Medicine at UCLA
Larissa Mooney, M.D. is a Professor of Clinical Psychiatry and Director of the Addiction Psychiatry Division in the Department of Psychiatry and Biobehavioral Sciences at UCLA. She also directs the UCLA Addiction Psychiatry Clinic and the UCLA–Veterans Affairs (VA) Addiction Psychiatry Fellowship Program, where she supervises and teaches psychiatrists in the clinical management of substance use and co-occurring mental health disorders. Dr. Mooney serves as Deputy Chief of the Substance Use Disorders Subdivision at the Greater Los Angeles VA. She is a Past President of the American Academy of Addiction Psychiatry (AAAP), a Fellow of the American Society of Addiction Medicine (ASAM), and a Distinguished Fellow of both the American Psychiatric Association (APA) and AAAP. Dr. Mooney is one of two Principal Investigators for the Greater Southern California Node of the National Institute on Drug Abuse (NIDA) Clinical Trials Network. Her research focuses on treatment interventions for substance use disorders.
760 Westwood Plaza, Suite 37-420
Los Angeles, CA 90095
Ph (310) 267-5419
LMooney@mednet.ucla.edu
Hser, Y. I., Mooney, L. J., Baldwin, L. M., Ober, A., Marsch, L. A., Sherman, S., Matthews, A., Clingan, S., Fei, Z., Zhu, Y., Dopp, A., Curtis, M. E., Osterhage, K. P., Hichborn, E. G., Lin, C., Black, M., Calhoun, S., Holtzer, C. C., Nesin, N., Bouchard, D., Saxon, A. J. (2023). Care coordination between rural primary care and telemedicine to expand medication treatment for opioid use disorder: Results from a single-arm, multisite feasibility study. The Journal of Rural Health, 10.1111/jrh.12760. Advance online publication. https://doi.org/10.1111/jrh.12760
Lin, C., Pham, H., Zhu, Y., Clingan, S. E., Lin, L. A., Murphy, S. M., Campbell, C. I., Sorrell, T. R., Liu, Y., Mooney, L. J., & Hser, Y. I. (2023). Telemedicine along the cascade of care for substance use disorders during the COVID-19 pandemic in the United States. Drug and alcohol dependence, 242, 109711. https://doi.org/10.1016/j.drugalcdep.2022.109711
Baskerville, W. A., Grodin, E. N., Lin, J., Miotto, K., Mooney, L. J., & Ray, L. A. (2023). Alcohol Use Among Treatment-Seeking Individuals with Opioid Use Disorder. Journal of Studies on Alcohol and Drugs, 10.15288/jsad.22-00176. Advance online publication. https://doi.org/10.15288/jsad.22-00176
Mooney L. J. (2022). Medication Treatment for Opioid Use Disorder Reduces Suicide Risk. The American Journal of Psychiatry, 179(4), 262–263. https://doi.org/10.1176/appi.ajp.20220173
Zhu, Y., Fei, Z., Mooney, L. J., Huang, K., & Hser, Y. I. (2022). Social Determinants of Mortality of COVID-19 and Opioid Overdose in American Rural and Urban Counties. Journal of Addiction Medicine, 16(1), e52–e55. https://doi.org/10.1097/ADM.0000000000000834
Mooney, L. J., Zhu, Y., Yoo, C. K., Wolitzky-Taylor, K., & Hser, Y. I. (2022). Association Between Benzodiazepine and Opioid Prescription and Mortality Among Patients in a Large Healthcare System. Journal of Addiction Medicine, 16(1), 65–71. https://doi.org/10.1097/ADM.0000000000000828
Hser, Y. I., Zhu, Y., Fei, Z., Mooney, L. J., Evans, E. A., Kelleghan, A., Matthews, A., Yoo, C., & Saxon, A. J. (2022). Long-term follow-up assessment of opioid use outcomes among individuals with comorbid mental disorders and opioid use disorder treated with buprenorphine or methadone in a randomized clinical trial. Addiction (Abingdon, England), 117(1), 151–161. https://doi.org/10.1111/add.15594
Salem, B. A., Gonzales-Castaneda, R., Ang, A., Rawson, R. A., Dickerson, D., Chudzynski, J., Penate, J., Dolezal, B., Cooper, C. B., & Mooney, L.J. (2022). Craving among individuals with stimulant use disorder in residential social model-based treatment - Can exercise help?. Drug and Alcohol Dependence, 231, 109247. https://doi.org/10.1016/j.drugalcdep.2021.109247
Zhu, Y., Mooney, L. J., Yoo, C., Evans, E. A., Kelleghan, A., Saxon, A. J., Curtis, M. E., & Hser, Y. I. (2021). Psychiatric comorbidity and treatment outcomes in patients with opioid use disorder: Results from a multisite trial of buprenorphine-naloxone and methadone. Drug and Alcohol Dependence, 228, 108996. https://doi.org/10.1016/j.drugalcdep.2021.108996
Mooney, L. J. (2019). The Assessment and Treatment of Addiction: Best Practices and New Frontiers. Elselvier, Inc. https://doi.org/10.1016/C2016-0-05129-X
Liao, J. Y., Mooney, L. J., Zhu, Y., Valdez, J., Yoo, C., & Hser, Y. I. (2019). Relationships between marijuana use, severity of marijuana-related problems, and health-related quality of life. Psychiatry Research, 279, 237–243. https://doi.org/10.1016/j.psychres.2019.03.010
Mooney, L. J., Zhu, Y., Yoo, C., Valdez, J., Moino, K., Liao, J. Y., & Hser, Y. I. (2018). Reduction in Cannabis Use and Functional Status in Physical Health, Mental Health, and Cognition. Journal of Neuroimmune Pharmacology, 13(4), 479–487. https://doi.org/10.1007/s11481-018-9813-6
Zhu, Y., Evans, E. A., Mooney, L. J., Saxon, A. J., Kelleghan, A., Yoo, C., & Hser, Y. I. (2018). Correlates of Long-Term Opioid Abstinence After Randomization to Methadone Versus Buprenorphine/Naloxone in a Multi-Site Trial. Journal of Neuroimmune Pharmacology, 13(4), 488–497. https://doi.org/10.1007/s11481-018-9801-x
Mooney, L. J., Hillhouse, M. P., Thomas, C., Ang, A., Sharma, G., Terry, G., Chang, L., Walker, R., Trivedi, M., Croteau, D., Sparenborg, S., & Ling, W. (2016). Utilizing a Two-stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-daily Bupropion as a Treatment for Methamphetamine Use Disorder. Journal of Addiction Medicine, 10(4), 236–243. https://doi.org/10.1097/ADM.0000000000000218
Mooney, L. J., Cooper, C., London, E. D., Chudzynski, J., Dolezal, B., Dickerson, D., Brecht, M. L., Peñate, J., & Rawson, R. A. (2014). Exercise for methamphetamine dependence: rationale, design, and methodology. Contemporary Clinical Trials, 37(1), 139–147. https://doi.org/10.1016/j.cct.2013.11.010
Mooney, L. J., Nielsen, S., Saxon, A., Hillhouse, M., Thomas, C., Hasson, A., Stablein, D., McCormack, J., Lindblad, R., & Ling, W. (2013). Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodology. Contemporary Clinical Trials, 34(2), 196–204. https://doi.org/10.1016/j.cct.2012.11.002